CURRENT NEWS

Centerwatch News

1. Good Pharma Scorecard results show continued drive for transparency

   Some of the world’s largest pharmaceu­tical companies have improved the transparency of their clinical trial data disclosures, according to new analysis from Bioethics International, yet many studies for approved drugs still go unreported. Bioethics International’s second Good Phar­ma Scorecard, published in the online medical journal BMJ Open, found that companies have made “meaningful progress” on […]

2. Dismantling silos key to improving the clinical trial continuum

   The focus on technology as a driver of performance improvement in clinical trials is intense, but despite years of valiant efforts, study execution remains far from optimal. For study startup, the data are dismal: Contract cycle times have doubled from an industry median of 1.5 months in 2009–2011 to more than three months in 2014–2015.1 […]

3. Egalet receives FDA tentative approval for expanded label for ARYMO ER

   Egalet, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced that the FDA has granted tentative approval for an expanded label for ARYMO ER (morphine sulfate) extended-release (ER) tablets C-II for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment […]

4. Evotec, CRTD partner to discover novel therapies for retinal diseases

   Evotec has entered into a research collaboration with the Center for Regenerative Therapies TU Dresden (CRTD) to discover novel small molecule candidates for retinal diseases. CRTD is a recognized leader in understanding the biology of stem cells to develop new therapies for neurodegenerative and hematological diseases. Under the terms of the collaboration, Evotec will leverage […]

5. CTI Clinical Trial and Consulting Services acquires Eurotrials

   CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service CRO, with more than 20 years of experience, and strong local expertise in Europe and Latin America. The acquisition strengthens CTI’s existing Real World Evidence business, adding significant presence and expertise in Europe […]

6. PAREXEL launches Perceptive Cloud

   PAREXEL International, a global biopharmaceutical services organization, introduced the Perceptive Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.   Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s […]

7. CluePoints hires Borders and Estrella

   CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team. Nick Borders and Rob Estrella join the CluePoints U.S. team to support its impressive global business growth, allowing the company to increase its expanding client base across North […]

8. Certara introduces New Investigator Awards program in Australia

   Certara, a global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). The presentation will take place today at the Australasian […]

9. First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

   COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]

10. Distributed Bio, Boehringer Ingelheim announce SuperHuman Platform Transfer

    Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce an agreement with Boehringer Ingelheim to license the Distributed Bio SuperHuman Platform for accelerating biotherapeutics discovery across therapeutic areas. “The SuperHuman Platform represents the culmination of a decade of our research in computational library design,” says Jacob […]